Bjoern Papke

3.0k total citations · 2 hit papers
12 papers, 1.2k citations indexed

About

Bjoern Papke is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Bjoern Papke has authored 12 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 4 papers in Oncology and 3 papers in Cell Biology. Recurrent topics in Bjoern Papke's work include Protein Kinase Regulation and GTPase Signaling (4 papers), Melanoma and MAPK Pathways (3 papers) and Pancreatic and Hepatic Oncology Research (2 papers). Bjoern Papke is often cited by papers focused on Protein Kinase Regulation and GTPase Signaling (4 papers), Melanoma and MAPK Pathways (3 papers) and Pancreatic and Hepatic Oncology Research (2 papers). Bjoern Papke collaborates with scholars based in Germany, United States and United Kingdom. Bjoern Papke's co-authors include Channing J. Der, Philippe I. H. Bastiaens, Nachiket Vartak, Herbert Waldmann, Alfred Wittinghofer, Shehab Ismail, Gunther Zimmermann, Maike Hoffmann, Gemma Triola and Stephan A. Hahn and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Bjoern Papke

12 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Small molecule inhibition of the KRAS–PDEδ interaction impairs oncogenic KRAS signalling

2013 474 citations Gunther Zimmermann, Bjoern Papke et al. Nature profile →
KRAS inhibitors: resistance drivers and combinatorial strategies

2024 52 citations Christine Sers, Channing J. Der et al. Trends in cancer profile →

Peers

Countries citing papers authored by Bjoern Papke

Since Specialization

Citations

This map shows the geographic impact of Bjoern Papke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bjoern Papke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bjoern Papke more than expected).

Fields of papers citing papers by Bjoern Papke

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bjoern Papke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bjoern Papke. The network helps show where Bjoern Papke may publish in the future.

Co-authorship network of co-authors of Bjoern Papke

This figure shows the co-authorship network connecting the top 25 collaborators of Bjoern Papke. A scholar is included among the top collaborators of Bjoern Papke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bjoern Papke. Bjoern Papke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

#	Work	Indexed citations
1	Enhancement of colorectal cancer therapy through interruption of the HSF1-HSP90 axis by p53 activation or cell cycle inhibition 2025 ·Cell Death and Differentiation ·(unknown), (unknown), Florian Wegwitz, Tiago De Oliveira, Lena‐Christin Conradi, Valery Volk, Friedrich Feuerhake, Bjoern Papke, Sebastian Stintzing, Bettina Mundt, Florian Kühnel, Ute M. Moll, Ramona Schulz‐Heddergott	5
2	KRAS inhibitors: resistance drivers and combinatorial strategies breakdown → 2024 ·Trends in cancer ·(unknown), Christine Sers, Channing J. Der, Bjoern Papke	52
3	Silencing of Oncogenic KRAS by Mutant-Selective Small Interfering RNA 2021 ·ACS Pharmacology & Translational Science ·Bjoern Papke, Salma H. Azam, (unknown), (unknown), (unknown), Pradeep S. Pallan, Amanda E.D. Van Swearingen, Martin Egli, Adrienne D. Cox, Channing J. Der, Chad V. Pecot	10
4	The KRAS-regulated kinome identifies WEE1 and ERK coinhibition as a potential therapeutic strategy in KRAS-mutant pancreatic cancer 2021 ·Journal of Biological Chemistry ·J. Nathaniel Diehl, Jennifer E. Klomp, (unknown), Priya S. Hibshman, Devon R. Blake, (unknown), Thomas S.K. Gilbert, Elisa Baldelli, Mariaelena Pierobon, Bjoern Papke, Runying Yang, Richard G. Hodge, Naim U. Rashid, Emanuel F. Petricoin, Laura E. Herring, Lee M. Graves, Adrienne D. Cox, Channing J. Der	21
5	Abstract B32: Silencing of oncogenic KRAS by a mutant-favoring short interfering RNA 2020 ·Molecular Cancer Research ·Bjoern Papke, Amanda E.D. Van Swearingen, (unknown), Salma H. Azam, Emily B. Harrison, Runying Yang, Adrienne D. Cox, Channing J. Der, Chad V. Pecot	2
6	Abstract LB-287: Combination therapies with CDK4/6 inhibitors to treat KRAS-mutant pancreatic cancer 2019 ·Cancer Research ·Craig M. Goodwin, (unknown), Andrew M. Waters, Bjoern Papke, Runying Yang, Mariaelena Pierobon, Daniel M. Freed, Patrick J. Roberts, Adrienne D. Cox, Kris C. Wood, Emanuel F. Petricoin, Autumn J. McRee, Channing J. Der	1
7	Drugging RAS: Know the enemy 2017 ·Science ·Bjoern Papke, Channing J. Der	266
8	Identification of pyrazolopyridazinones as PDEδ inhibitors 2016 ·Nature Communications ·Bjoern Papke, Sandip Murarka, (unknown), Pablo Martín‐Gago, Marija Kovačević, Dina C. Truxius, Eyad K. Fansa, Shehab Ismail, Gunther Zimmermann, (unknown), Carsten Schultz‐Fademrecht, (unknown), Matthias Baumann, Peter Nußbaumer, Alfred Wittinghofer, Herbert Waldmann, Philippe I. H. Bastiaens	131
9	KRas Localizes to the Plasma Membrane by Spatial Cycles of Solubilization, Trapping and Vesicular Transport 2014 ·Cell ·Malte Schmick, Nachiket Vartak, Bjoern Papke, Marija Kovačević, Dina C. Truxius, Lisaweta Roßmannek, Philippe I. H. Bastiaens	187
10	The Autodepalmitoylating Activity of APT Maintains the Spatial Organization of Palmitoylated Membrane Proteins 2014 ·Biophysical Journal ·Nachiket Vartak, Bjoern Papke, Hernán E. Grecco, Lisaweta Roßmannek, Herbert Waldmann, Christian Hedberg, Philippe I. H. Bastiaens	71
11	Small molecule inhibition of the KRAS–PDEδ interaction impairs oncogenic KRAS signalling breakdown → 2013 ·Nature ·Gunther Zimmermann, Bjoern Papke, Shehab Ismail, Nachiket Vartak, Anchal Chandra, Maike Hoffmann, Stephan A. Hahn, Gemma Triola, Alfred Wittinghofer, Philippe I. H. Bastiaens, Herbert Waldmann	474
12	Precise measurement of protein interacting fractions with fluorescence lifetime imaging microscopy 2011 ·Molecular BioSystems ·Kirstin A. Walther, Bjoern Papke, (unknown), (unknown), Ali Kinkhabwala	28

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact